Fifteen Collies, previously having mild reactions to ivermectin challenge (120 - mu - g / kg of body weight; 20 times the recommended dosage level), were studied to evaluate the effects of
milbemycin oxime administration at 5 and 10 mg / kg (10 and 20 times the manufacturer's recommended dosage).
Not exact matches
TRIFEXIS (spinosad and
milbemycin oxime) is available in five sizes for oral
administration to dogs and puppies according to their weight.
The following adverse reactions have been reported in dogs after
administration of
milbemycin oxime, lufenuron, or praziquantel: vomiting, depression / lethargy, pruritus, urticaria, diarrhea, anorexia, skin congestion, ataxia, convulsions, salivation, and weakness.
Trifexis ® (spinosad +
milbemycin oxime) is a prescription product approved by the Federal Drug
Administration (FDA) that should only be obtained through a licensed veterinarian with whom you have a proper vet - client - patient relationship (VCPR).
The following adverse reactions have been reported in dogs after
administration of
milbemycin oxime or praziquantel: vomiting, diarrhea, depression / lethargy, ataxia, anorexia, convulsions, weakness, and salivation.
Prior to
administration of Interceptor ® Plus (
milbemycin oxime / praziquantel), dogs should be tested for existing heartworm infections.
The following adverse reactions have been reported in dogs after
administration of
milbemycin oxime or praziquantel, the active ingredients in Interceptor Plus: vomiting, diarrhea, depression / lethargy, incoordination, decreased appetite, convulsions, weakness, and salivation.